Overview

A Pharmacokinetic Study of Three Different Particle Sizes of PH-797804

Status:
Withdrawn
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effects of varying particle size on the pharmacokinetics of PH-797804
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer